Dare Bioscience, Inc. (DARE) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Dare Bioscience, Inc. (DARE) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

DARE Income Statement

Dare Bioscience, Inc. (DARE) annual income statement — 15-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	187.55K	152.46K	1.02M	2.26K	-21.17K	25.43K	-63.65K	41.69K	22.44K	9.3K	1.81M	1M	0	0	0	0	10M	0	0	0
Revenue Growth %	985.82%	499.58%	1708.36%	-94.57%	-194.36%	173.35%	-103.52%	-95.83%	-	-	-	-	-100%	-	-	-	-	-	-	-
Cost of Goods Sold	319.89K	796.97K	295.8K	1.18M	0	2.3M	14.22M	25K	0	3.36M	21.56M	25K	25K	25K	4.72K	25K	25K	25K	25K	25K
COGS % of Revenue	170.57%	522.76%	28.9%	51952.61%	-	9035.2%	-22345.96%	59.97%	-	36134.1%	1192.72%	2.5%	-	-	-	-	0.25%	-	-	-
Gross Profit	-132.34K	-644.51K	727.88K	-1.17M	-21.17K	-2.27M	-14.29M	16.69K	22.44K	-3.35M	-19.76M	975K	-25K	-25K	-4.72K	-25K	9.97M	-25K	-25K	-25K
Gross Margin %	-70.57%	-422.76%	71.1%	-51852.61%	100%	-8935.2%	22445.96%	40.03%	100%	-36034.1%	-1092.72%	97.5%	-	-	-	-	99.75%	-	-	-
Gross Profit Growth %	-525.09%	71.63%	105.09%	-7127.18%	-194.36%	32.22%	27.68%	-98.29%	189.75%	-13307.57%	-	4000%	-100.25%	0%	81.13%	0%	40000%	0%	0%	0%
Operating Expenses	2.84M	2.35M	2.2M	2.5M	3.81M	2.31M	-8.9M	4.7M	7.38M	2.67M	-14.58M	9.37M	8.96M	8.36M	16.2M	7.11M	9.59M	8.38M	9.52M	12.64M
OpEx % of Revenue	1511.97%	1544.31%	214.83%	110488.15%	-17979.54%	9081.54%	13980.21%	11268.72%	32899.12%	28709.75%	-806.67%	937.14%	-	-	-	-	95.91%	-	-	-
Selling, General & Admin	2.59M	2.25M	1.58M	2.5M	2.38M	2.31M	2M	2.04M	2.45M	2.67M	2.95M	2.7M	2.92M	3.34M	3.25M	2.65M	2.79M	2.57M	2.4M	2.21M
SG&A % of Revenue	1382.95%	1474.9%	154.06%	110488.15%	-11231.18%	9081.54%	-3136.18%	4896.18%	10910.64%	28709.75%	163.44%	269.68%	-	-	-	-	27.93%	-	-	-
Research & Development	241.97K	152.46K	622.04K	1.18M	1.43M	2.3M	3.31M	2.66M	4.93M	3.35M	3.8M	6.67M	6.04M	5.02M	12.98M	4.46M	6.8M	5.81M	7.12M	10.43M
R&D % of Revenue	129.02%	100%	60.77%	51952.61%	-6748.36%	9035.2%	-5202.35%	6372.53%	21988.47%	36051.6%	210.16%	667.46%	-	-	-	-	67.98%	-	-	-
Other Operating Expenses	0	-46.64K	0	-1000K	0	-1000K	-1000K	0	0	-1000K	-1000K	0	0	0	0	0	0	0	0	0
Operating Income	-2.97M	-3M	-1.47M	-3.67M	-3.83M	-4.58M	-5.39M	-4.68M	-7.36M	-6.02M	-5.17M	-8.4M	-8.99M	-8.38M	-16.21M	-7.14M	384.32K	-8.4M	-9.54M	-12.67M
Operating Margin %	-1582.53%	-1967.07%	-143.72%	-162340.76%	18079.54%	-18016.75%	8465.75%	-11228.68%	-32799.12%	-64743.85%	-286.05%	-839.64%	-	-	-	-	3.84%	-	-	-
Operating Income Growth %	22.46%	34.54%	72.69%	21.56%	47.99%	23.93%	-4.19%	44.25%	18.13%	28.16%	68.09%	-17.62%	-2439.02%	0.21%	-69.81%	43.65%	104.19%	-9.19%	-13.06%	-67.1%
EBITDA	-2.4M	-2.44M	-936.87K	-3.19M	-3.37M	-4.42M	-5.38M	-4.67M	-7.34M	-6.01M	-5.16M	-8.39M	-8.98M	-8.37M	-16.2M	-7.14M	389.64K	-8.4M	-9.54M	-12.66M
EBITDA Margin %	-1277.47%	-1603.26%	-91.52%	-141036.34%	15906.5%	-17394.93%	8455.75%	-11205.31%	-32730.32%	-64627.98%	-285.5%	-838.72%	-	-	-	-	3.9%	-	-	-
EBITDA Growth %	28.86%	44.74%	82.59%	31.71%	54.14%	26.43%	-4.27%	44.3%	18.22%	28.2%	68.14%	-17.54%	-2404.62%	0.26%	-69.89%	43.65%	104.26%	-9.21%	-13.07%	-67.29%
D&A (Non-Cash Add-back)	572.14K	554.64K	534.39K	481.91K	460.07K	158.11K	6.37K	9.74K	15.44K	10.78K	9.98K	9.26K	9.62K	9.51K	4.72K	3.03K	5.32K	5.23K	7.05K	6.34K
EBIT	-2.95M	-2.8M	-1.44M	-3.56M	-3.75M	-4.38M	-5.51M	-4.7M	12.91M	-6.76M	-4.97M	-8.4M	-8.99M	-8.38M	-15.94M	-7.14M	384.32K	-8.4M	-9.54M	-12.67M
Net Interest Income	0	-7.71K	0	0	-198.69K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Income	0	191.69K	0	0	69.85K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Expense	0	199.39K	0	0	268.53K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	-14.79K	-991	29.55K	109.38K	-188.68K	202.81K	-118.2K	-21.15K	20.27M	-732.88K	113.9K	97.32K	227.12K	340.15K	262.34K	118.95K	29.68K	1.78K	834	1.51K
Pretax Income	-2.98M	-3M	-1.44M	-3.56M	-4.02M	-4.38M	-5.51M	-4.7M	12.91M	-6.76M	-5.06M	-8.3M	-8.76M	-8.04M	-15.94M	-7.02M	414K	-8.4M	-9.54M	-12.67M
Pretax Margin %	-1590.42%	-1967.72%	-140.84%	-157505.13%	18970.73%	-17219.13%	8651.47%	-11279.42%	57539.25%	-72622.62%	-279.75%	-829.91%	-	-	-	-	4.14%	-	-	-
Income Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	-2.98M	-3M	-1.44M	-3.56M	-4.02M	-4.38M	-5.51M	-4.7M	12.91M	-6.76M	-5.06M	-8.3M	-8.76M	-8.04M	-15.94M	-7.02M	414K	-8.4M	-9.54M	-12.67M
Net Margin %	-1590.42%	-1967.72%	-140.84%	-157505.13%	18970.73%	-17219.13%	8651.47%	-11279.42%	57539.25%	-72622.62%	-279.75%	-829.91%	-	-	-	-	4.14%	-	-	-
Net Income Growth %	25.74%	31.48%	73.82%	24.24%	-131.11%	35.19%	-8.87%	43.34%	247.34%	16%	68.28%	-18.22%	-2216.49%	4.24%	-67.08%	44.58%	104.52%	-14.68%	-13.04%	-67.05%
Net Income (Continuing)	-2.98M	-3M	-1.44M	-3.56M	-4.02M	-4.38M	-5.51M	-4.7M	12.91M	-6.76M	-5.06M	-8.3M	-8.76M	-8.04M	-15.94M	-7.02M	414K	-8.4M	-9.54M	-12.67M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.20	-0.21	-0.10	-0.28	-0.45	-0.50	-0.65	-0.55	1.52	-0.81	-0.69	-1.09	-1.22	-1.13	-2.34	-0.98	0.06	-0.10	-0.13	-2.97
EPS Growth %	55.56%	58%	84.71%	49.09%	-129.61%	38.27%	5.8%	49.54%	224.59%	28.32%	70.51%	-11.22%	-2196.22%	-1030%	-1700%	67%	132.33%	37.5%	51.85%	-1137.5%
EPS (Basic)	-0.20	-0.21	-0.10	-0.28	-0.45	-0.50	-0.65	-0.55	1.53	-0.81	-0.69	-1.09	-1.22	-1.13	-2.34	-0.98	0.06	-0.10	-0.13	-0.18
Diluted Shares Outstanding	14.89M	14.52M	14.5M	12.76M	8.87M	8.76M	8.5M	8.53M	8.48M	8.38M	7.3M	7.59M	7.2M	7.13M	6.8M	7.07M	7.11M	7M	4.34M	4.27M
Basic Shares Outstanding	14.89M	14.52M	14.5M	12.76M	8.87M	8.76M	8.5M	8.53M	8.41M	8.38M	7.3M	7.59M	7.2M	7.13M	6.8M	7.07M	7.11M	7M	4.34M	4.27M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-